Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.

Weiss BM, Minter A, Abadie J, Howard R, Ascencao J, Schechter GP, Kuehl M, Landgren O.

Am J Hematol. 2011 Jun;86(6):475-8. doi: 10.1002/ajh.22025. Epub 2011 May 4.

PMID:
21544856
[PubMed - indexed for MEDLINE]
2.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M; International Myeloma Working Group.

Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22. Review.

PMID:
20410922
[PubMed - indexed for MEDLINE]
3.

AHRQ series paper 3: identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program.

Whitlock EP, Lopez SA, Chang S, Helfand M, Eder M, Floyd N.

J Clin Epidemiol. 2010 May;63(5):491-501. doi: 10.1016/j.jclinepi.2009.03.008. Epub 2009 Jun 21.

PMID:
19540721
[PubMed - indexed for MEDLINE]
4.

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG; International Myeloma Working Group.

Leukemia. 2009 Feb;23(2):215-24. doi: 10.1038/leu.2008.307. Epub 2008 Nov 20. Review.

PMID:
19020545
[PubMed - indexed for MEDLINE]
5.

Epidemiology of the plasma-cell disorders.

Kyle RA, Rajkumar SV.

Best Pract Res Clin Haematol. 2007 Dec;20(4):637-64. Review.

PMID:
18070711
[PubMed - indexed for MEDLINE]
6.

Multiple myeloma: charging toward a bright future.

Katzel JA, Hari P, Vesole DH.

CA Cancer J Clin. 2007 Sep-Oct;57(5):301-18. Review.

PMID:
17855486
[PubMed - indexed for MEDLINE]
Free Article
7.

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.

Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C, Dimou M, Kyriakou E, Angelopoulou MK, Dimopoulou MN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Panayiotidis P, Pangalis GA.

Br J Haematol. 2007 May;137(3):240-3.

PMID:
17408464
[PubMed - indexed for MEDLINE]
8.

Cancer statistics, 2007.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ.

CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66.

PMID:
17237035
[PubMed - indexed for MEDLINE]
9.

International uniform response criteria for multiple myeloma.

Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group.

Leukemia. 2006 Sep;20(9):1467-73. Epub 2006 Jul 20. Erratum in: Leukemia. 2007 May;21(5):1134. Leukemia. 2006 Dec;20(12):2220.

PMID:
16855634
[PubMed - indexed for MEDLINE]
10.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G.

Am J Hematol. 2005 Aug;79(4):319-28. Review.

PMID:
16044444
[PubMed - indexed for MEDLINE]
11.

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.

Sanchorawala V, Seldin DC, Magnani B, Skinner M, Wright DG.

Bone Marrow Transplant. 2005 Oct;36(7):597-600.

PMID:
16044137
[PubMed - indexed for MEDLINE]
12.

Serum free light chain measurements move to center stage.

Bradwell AR.

Clin Chem. 2005 May;51(5):805-7. No abstract available.

PMID:
15855664
[PubMed - indexed for MEDLINE]
Free Article
13.

Serum free light chains for monitoring multiple myeloma.

Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR.

Br J Haematol. 2004 Aug;126(3):348-54.

PMID:
15257706
[PubMed - indexed for MEDLINE]
14.

Pharmacotherapy of multiple myeloma: an economic perspective.

Messori A, Trippoli S, Santarlasci B.

Expert Opin Pharmacother. 2003 Apr;4(4):515-24. Review.

PMID:
12667114
[PubMed - indexed for MEDLINE]
15.

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R.

Clin Chem. 2001 Apr;47(4):673-80.

PMID:
11274017
[PubMed - indexed for MEDLINE]
Free Article
16.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk